Sex affects immunity.

[1]  G. Valesini,et al.  Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[2]  K. Ueno,et al.  Association of Rsa polymorphism of the estrogen receptor-β gene with rheumatoid arthritis , 2012, Rheumatology International.

[3]  D. Choubey,et al.  Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[4]  D. Gilroy,et al.  Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. , 2011, Blood.

[5]  C. Libert,et al.  X‐chromosome‐located microRNAs in immunity: Might they explain male/female differences? , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[6]  I. Bruce,et al.  Systemic lupus erythematosus, regulatory T cells and pregnancy , 2011, Expert review of clinical immunology.

[7]  Ghina Ghazeeri,et al.  Immunological Differences in Women Compared with Men: Overview and Contributing Factors , 2011, American journal of reproductive immunology.

[8]  Chang H. Kim,et al.  Progesterone Promotes Differentiation of Human Cord Blood Fetal T Cells into T Regulatory Cells but Suppresses Their Differentiation into Th17 Cells , 2011, The Journal of Immunology.

[9]  Takashi Shimizu,et al.  Evidence that polymorphonuclear neutrophils infiltrate into the developing corpus luteum and promote angiogenesis with interleukin-8 in the cow , 2011, Reproductive biology and endocrinology : RB&E.

[10]  J. Harley,et al.  Klinefelter’s syndrome (47,XXY) among men with systemic lupus erythematosus , 2011, Acta paediatrica.

[11]  P. Mccombe,et al.  Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms , 2011, Journal of Neuroimmunology.

[12]  S. Ahmed,et al.  MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. , 2011, Translational research : the journal of laboratory and clinical medicine.

[13]  S. Sánchez-Ramón,et al.  Estradiol‐dependent perforin expression by human regulatory T‐cells , 2011, European journal of clinical investigation.

[14]  M. Lagerquist,et al.  Estrogens in rheumatoid arthritis; the immune system and bone , 2011, Molecular and Cellular Endocrinology.

[15]  C. Whitacre,et al.  Estriol Generates Tolerogenic Dendritic Cells In Vivo That Protect against Autoimmunity , 2011, The Journal of Immunology.

[16]  M. Petri,et al.  Abnormal Production of Pro- and Anti-Inflammatory Cytokines by Lupus Monocytes in Response to Apoptotic Cells , 2011, PloS one.

[17]  A. Vandenbark,et al.  Oestrogen‐mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells , 2011, Immunology.

[18]  C. Grimaldi,et al.  Differential Roles of Estrogen Receptors α and β in Control of B-Cell Maturation and Selection , 2011, Molecular medicine.

[19]  M. Zouali,et al.  The Multi-faceted Influences of Estrogen on Lymphocytes: Toward Novel Immuno-interventions Strategies for Autoimmunity Management , 2011, Clinical reviews in allergy & immunology.

[20]  S. Walker.  Estrogen and Autoimmune Disease , 2011, Clinical reviews in allergy & immunology.

[21]  E. Peeva,et al.  Prolactin, Systemic Lupus Erythematosus, and Autoreactive B Cells: Lessons Learnt from Murine Models , 2011, Clinical reviews in allergy & immunology.

[22]  G. Gilkeson,et al.  Estrogen Receptors in Immunity and Autoimmunity , 2011, Clinical reviews in allergy & immunology.

[23]  B. Diamond,et al.  Current and novel therapeutics in the treatment of systemic lupus erythematosus , 2011 .

[24]  J. Braun,et al.  Regulatory B cells in autoimmune diseases and mucosal immune homeostasis , 2011, Autoimmunity.

[25]  K. Safranow,et al.  The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide. , 2011, Pharmacogenomics.

[26]  C. Sun,et al.  Estrogen enhances the functions of CD4+CD25+Foxp3+ regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro , 2011, Cellular and Molecular Immunology.

[27]  M. Lagerquist,et al.  Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis , 2010, BMC musculoskeletal disorders.

[28]  G. Herrero-Beaumont,et al.  Efficacy and safety of a selective estrogen receptor β agonist, ERB‐041, in patients with rheumatoid arthritis: A 12‐week, randomized, placebo‐controlled, phase II study , 2010, Arthritis care & research.

[29]  D. Choubey,et al.  Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[30]  D. Khan,et al.  Estrogen increases, whereas IL‐27 and IFN‐γ decrease, splenocyte IL‐17 production in WT mice , 2010, European journal of immunology.

[31]  C. Cho,et al.  Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus , 2010, Clinical and experimental immunology.

[32]  M. Coenen,et al.  Skewed X-chromosomal inactivation impacts T regulatory cell function in systemic sclerosis , 2010, Journal of Translational Medicine.

[33]  M. Steffl,et al.  Estrous cycle-dependent activity of neutrophils in the porcine endometrium: possible involvement of heat shock protein 27 and lactoferrin. , 2010, Animal reproduction science.

[34]  J. Farrar,et al.  Cutting Edge: Type I IFN Reverses Human Th2 Commitment and Stability by Suppressing GATA3 , 2010, The Journal of Immunology.

[35]  T. Therneau,et al.  Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. , 2010, Arthritis and rheumatism.

[36]  D. Choubey,et al.  Mutually Positive Regulatory Feedback Loop between Interferons and Estrogen Receptor-α in Mice: Implications for Sex Bias in Autoimmunity , 2010, PloS one.

[37]  Philippa Marrack,et al.  Genetic and hormonal factors in female-biased autoimmunity. , 2010, Autoimmunity reviews.

[38]  Andrew Pekosz,et al.  The Xs and Y of immune responses to viral vaccines. , 2010, The Lancet. Infectious diseases.

[39]  J. Ernerudh,et al.  FOXP3+ Regulatory T Cells and T Helper 1, T Helper 2, and T Helper 17 Cells in Human Early Pregnancy Decidua1 , 2010, Biology of reproduction.

[40]  M. Lockshin.  Nonhormonal explanations for sex discrepancy in human illness , 2010, Annals of the New York Academy of Sciences.

[41]  M. Clowse,et al.  The management of rheumatic diseases in pregnancy , 2010, Scandinavian journal of rheumatology.

[42]  B. Dijkmans,et al.  The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine. , 2010, Arthritis and rheumatism.

[43]  G. Tsokos,et al.  Pathogenesis of human systemic lupus erythematosus: recent advances. , 2010, Trends in molecular medicine.

[44]  Yong-tang Zheng,et al.  The Influence of Age and Sex on the Cell Counts of Peripheral Blood Leukocyte Subpopulations in Chinese Rhesus Macaques , 2009, Cellular and Molecular Immunology.

[45]  S. Vukusic,et al.  The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement , 2009, Journal of the Neurological Sciences.

[46]  C. Pozzilli,et al.  Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment , 2009, Journal of the Neurological Sciences.

[47]  A. Achiron,et al.  Gender effects in relapsing–remitting multiple sclerosis: Correlation between clinical variables and gene expression molecular pathways , 2009, Journal of the Neurological Sciences.

[48]  J. Wolinsky,et al.  Glatiramer acetate treatment in PPMS: Why males appear to respond favorably , 2009, Journal of the Neurological Sciences.

[49]  A. Silman,et al.  Why are women predisposed to autoimmune rheumatic diseases? , 2009, Arthritis research & therapy.

[50]  R. Straub,et al.  Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis. , 2009, Arthritis and rheumatism.

[51]  E. Steegers,et al.  First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis , 2009, Multiple sclerosis.

[52]  N. Rose,et al.  Sex Differences in a Murine Model of Sjögren's Syndrome , 2009, Annals of the New York Academy of Sciences.

[53]  M. Lindsay,et al.  microRNAs and the immune response. , 2008, Trends in immunology.

[54]  S. Gold,et al.  Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERα) , 2009, Laboratory Investigation.

[55]  A. Vandenbark,et al.  Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin‐17 production via programmed death 1 , 2009, Immunology.

[56]  A. Taniguchi,et al.  The Influence of Sex on Patients with Rheumatoid Arthritis in a Large Observational Cohort , 2009, The Journal of Rheumatology.

[57]  A. Bottaro,et al.  Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. , 2009, Molecular endocrinology.

[58]  S. Pauklin,et al.  Estrogen directly activates AID transcription and function , 2009, The Journal of experimental medicine.

[59]  B. Bresnihan,et al.  Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study , 2009, Arthritis research & therapy.

[60]  A. Sawalha,et al.  Dehydroepiandrosterone in systemic lupus erythematosus , 2008, Current rheumatology reports.

[61]  F. Guillemin,et al.  Natural history of multiple sclerosis in a population‐based cohort , 2008, European journal of neurology.

[62]  N. Rose,et al.  Sex differences in autoimmune disease from a pathological perspective. , 2008, The American journal of pathology.

[63]  E. Fish.  The X-files in immunity: sex-based differences predispose immune responses , 2008, Nature Reviews Immunology.

[64]  S. Gold,et al.  Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone , 2008, Journal of Neuroinflammation.

[65]  E. Uz,et al.  Skewed X-Chromosome Inactivation in Scleroderma , 2008, Clinical reviews in allergy & immunology.

[66]  Xiaolan Li,et al.  Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial. , 2008, Journal of Rheumatology.

[67]  M. Petri.  Sex hormones and systemic lupus erythematosus , 2008, Lupus.

[68]  D. Gray,et al.  Not always the bad guys: B cells as regulators of autoimmune pathology , 2008, Nature Reviews Immunology.

[69]  B. Howard,et al.  Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. , 2008, Arthritis and rheumatism.

[70]  Shizhong Han,et al.  Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus , 2008, PloS one.

[71]  I. Moldovan,et al.  Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens , 2008, Journal of Neuroimmunology.

[72]  M. Debouverie,et al.  LORSEP GROUP. NATURAL HISTORY OF MULTIPLE SCLEROSIS IN A POPULATION BASED COHORT , 2008 .

[73]  H. Volk,et al.  Kinetics of Regulatory T Cells During Murine Pregnancy , 2007, American journal of reproductive immunology.

[74]  H. Dao,et al.  Gender differences in skin: a review of the literature. , 2007, Gender medicine.

[75]  C. Gordon,et al.  Pregnancy and rheumatic diseases. , 2007, Rheumatology.

[76]  A. Pernis.  Estrogen and CD4+ T cells , 2007, Current opinion in rheumatology.

[77]  Y. Shoenfeld,et al.  Hyperprolactinemia and autoimmune diseases. , 2007, Autoimmunity reviews.

[78]  C. Goodnow.  Multistep Pathogenesis of Autoimmune Disease , 2007, Cell.

[79]  I. Hafström,et al.  Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function. , 2007, The Journal of rheumatology.

[80]  Margaret Warner,et al.  Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.

[81]  Y. Shoenfeld,et al.  Gender and autoimmunity. , 2007, Autoimmunity reviews.

[82]  R. Elashoff,et al.  Testosterone treatment in multiple sclerosis: a pilot study. , 2007, Archives of neurology.

[83]  W. Grizzle,et al.  Overexpression of Activation-Induced Cytidine Deaminase in B Cells Is Associated with Production of Highly Pathogenic Autoantibodies1 , 2007, The Journal of Immunology.

[84]  Elizabeth W Karlson,et al.  Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. , 2007, Arthritis and rheumatism.

[85]  A. Banham,et al.  Expansion of CD4+CD25+and FOXP3+ Regulatory T Cells during the Follicular Phase of the Menstrual Cycle: Implications for Human Reproduction1 , 2007, The Journal of Immunology.

[86]  D. Barad,et al.  Gender as risk factor for autoimmune diseases. , 2007, Journal of autoimmunity.

[87]  Wentian Li,et al.  Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus , 2006, PLoS medicine.

[88]  P. Emery,et al.  Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. , 2006, Rheumatology.

[89]  Xiaolan Li,et al.  Differential expression of estrogen receptors in women with systemic lupus erythematosus. , 2006, The Journal of rheumatology.

[90]  C. Perreault,et al.  Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[91]  B. Diamond,et al.  Cutting Edge: Hormonal Milieu, Not Antigenic Specificity, Determines the Mature Phenotype of Autoreactive B Cells1 , 2006, The Journal of Immunology.

[92]  L. Ackerman.  Sex hormones and the genesis of autoimmunity. , 2006, Archives of dermatology.

[93]  G. Rice,et al.  The natural history of multiple sclerosis. , 2006, Advances in neurology.

[94]  C. Grimaldi,et al.  Sex hormones and SLE: influencing the fate of autoreactive B cells. , 2006, Current topics in microbiology and immunology.

[95]  Y. Kawana,et al.  Female steroid hormones use signal transducers and activators of transcription protein-mediated pathways to modulate the expression of T-bet in epithelial cells: a mechanism for local immune regulation in the human reproductive tract. , 2005, Molecular endocrinology.

[96]  M. Heineman,et al.  Sex hormones and the immune response in humans. , 2005, Human reproduction update.

[97]  Maurizio Cutolo,et al.  Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy. , 2005, The Journal of rheumatology.

[98]  C. Grimaldi,et al.  Hormonal modulation of B cell development and repertoire selection. , 2005, Molecular immunology.

[99]  R. Kvetňanský,et al.  Hormone concentrations in synovial fluid of patients with rheumatoid arthritis. , 2005, Clinical and experimental rheumatology.

[100]  R. Voll,et al.  Impaired clearance of dying cells in systemic lupus erythematosus. , 2005, Autoimmunity reviews.

[101]  H. Willard,et al.  X-inactivation profile reveals extensive variability in X-linked gene expression in females , 2005, Nature.

[102]  David Handelsman,et al.  Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis , 2005, Clinical Endocrinology.

[103]  L. Klareskog,et al.  Role of T lymphocytes in murine collagen induced arthritis , 1986, Agents and Actions.

[104]  T. Niewold,et al.  Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C , 2005, Clinical Rheumatology.

[105]  M. Peterson,et al.  Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus , 2004 .

[106]  A. Achiron,et al.  Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis , 2004, Journal of Neurology.

[107]  S. Ziegler,et al.  Cutting Edge: Estrogen Drives Expansion of the CD4+CD25+ Regulatory T Cell Compartment1 , 2004, The Journal of Immunology.

[108]  M. Heineman,et al.  Gender Difference in the Non‐Specific and Specific Immune Response in Humans , 2004, American journal of reproductive immunology.

[109]  A. A. Drosos,et al.  Epidemiology of rheumatoid arthritis. , 2004, Autoimmunity reviews.

[110]  M. Pender,et al.  Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls. , 2004, Journal of autoimmunity.

[111]  Christian Confavreux,et al.  Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. , 2004, Brain : a journal of neurology.

[112]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[113]  M. Cutolo.  Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. , 2004, The Journal of rheumatology.

[114]  Takashi Suzuki,et al.  Sex steroid receptors in rheumatoid arthritis. , 2004, Clinical science.

[115]  Tomomasa Watanabe,et al.  A molecular genetic linkage map of mouse chromosome 19, including thelpr, Ly-44, andTdt genes , 1991, Biochemical Genetics.

[116]  M. Peterson,et al.  Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[117]  L. Felländer-Tsai,et al.  Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. , 2003, The Journal of rheumatology.

[118]  C. Lau,et al.  Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[119]  M. Sheridan-Pereira,et al.  Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. , 2003, Blood.

[120]  D. Mellström,et al.  Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. , 2003, The Journal of rheumatology.

[121]  F. Tanrıverdi,et al.  The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. , 2003, The Journal of endocrinology.

[122]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[123]  G. Mor,et al.  Interaction of the Estrogen Receptors with the Fas Ligand Promoter in Human Monocytes1 , 2003, The Journal of Immunology.

[124]  S. Gabriel,et al.  Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. , 2003, Arthritis and rheumatism.

[125]  U. Kayisli,et al.  Estradiol suppresses vascular monocyte chemotactic protein-1 expression during early atherogenesis. , 2002, American journal of obstetrics and gynecology.

[126]  Seth E. Bouvier,et al.  Treatment of multiple sclerosis with the pregnancy hormone estriol , 2002, Annals of neurology.

[127]  C. Grimaldi,et al.  Estrogen alters thresholds for B cell apoptosis and activation. , 2002, The Journal of clinical investigation.

[128]  R. Straub,et al.  Cortisol, Dehydroepiandrosterone Sulfate, and Androstenedione Levels in Patients with Polymyalgia Rheumatica during Twelve Months of Glucocorticoid Therapy , 2002, Annals of the New York Academy of Sciences.

[129]  R. Shames.  Gender differences in the development and function of the immune system. , 2002, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[130]  I. Hafström,et al.  Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism. , 2002, Rheumatology.

[131]  S. Sawcer,et al.  HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[132]  Chernyshov Vp,et al.  Effect of female steroid hormones on expression of adhesion molecules by peripheral blood leukocytes , 2002 .

[133]  S. Gabriel,et al.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. , 2002, The Journal of rheumatology.

[134]  M. Evans,et al.  Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. , 2001, The Journal of rheumatology.

[135]  J. McConnell,et al.  Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity , 2001, Annals of the rheumatic diseases.

[136]  C. Grimaldi,et al.  Cutting Edge: Expansion and Activation of A Population of Autoreactive Marginal Zone B Cells in a Model of Estrogen-Induced Lupus , 2001, The Journal of Immunology.

[137]  D. Li,et al.  Randomized controlled trial of interferon-beta-1a in secondary progressive MS , 2001, Neurology.

[138]  D. Verthelyi.  Sex hormones as immunomodulators in health and disease. , 2001, International immunopharmacology.

[139]  R. Mcmurray,et al.  Estrogen, prolactin, and autoimmunity: actions and interactions. , 2001, International immunopharmacology.

[140]  B. Polgár,et al.  Progesterone as an immunomodulatory molecule. , 2001, International immunopharmacology.

[141]  T. Lehtimäki,et al.  Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women , 2001, Neurology.

[142]  G. Yovel,et al.  The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. , 2001, Gynecologic oncology.

[143]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[144]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[145]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[146]  K. Tamaki,et al.  Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[147]  H. Mossmann,et al.  Functional testosterone receptors in plasma membranes of T cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[148]  M. Hutchinson,et al.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. , 1999, The New England journal of medicine.

[149]  M. Hutchinson,et al.  Rate of Pregnancy-Related Relapse in Multiple Sclerosis , 1998 .

[150]  R. Voll,et al.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[151]  G. Giese,et al.  Estradiol binding to cell surface raises cytosolic free calcium in T cells , 1998, FEBS letters.

[152]  J. Jacobs,et al.  Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. , 1996, Annals of the rheumatic diseases.

[153]  N. Olsen,et al.  Gonadal steroids and immunity. , 1996, Endocrine reviews.

[154]  G. Danieli,et al.  Genetic control of the CD4/CD8 T-cell ratio in humans , 1995, Nature Medicine.

[155]  A. Masi,et al.  Perspectives on sex hormones and the systemic rheumatic diseases. , 1995, Clinical and experimental rheumatology.

[156]  C. Peterson,et al.  Cyclic Changes in the Concentrations of Peripheral Blood Immune Cells During the Normal Menstrual Cycle , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[157]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[158]  T. Spector,et al.  A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. , 1994, Annals of the rheumatic diseases.

[159]  S. Ralston,et al.  Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study. , 1994, Annals of the rheumatic diseases.

[160]  J. Jacobs,et al.  Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis. , 1993, Annals of the rheumatic diseases.

[161]  O. Andersen,et al.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. , 1993, Brain : a journal of neurology.

[162]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. , 1991, Brain : a journal of neurology.

[163]  M. Cutolo,et al.  Androgen replacement therapy in male patients with rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[164]  G. Verbruggen,et al.  Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. , 1990, The Journal of rheumatology.

[165]  L. Rönnblom,et al.  Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour , 1990, Journal of internal medicine.

[166]  R. Holmdahl,et al.  Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect. , 1989, Journal of reproductive immunology.

[167]  A. Silman,et al.  Evidence for similarity in testosterone levels in haplotype identical brothers. , 1988, Disease markers.

[168]  J. Bijlsma,et al.  Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis. , 1987, Annals of the rheumatic diseases.

[169]  A. Notkins,et al.  Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.

[170]  B. Bain,et al.  TOTAL AND DIFFERENTIAL LEUCOCYTE COUNT , 1976, British journal of haematology.